{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:47:54Z","timestamp":1776116874244,"version":"3.50.1"},"reference-count":162,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2023\/002508"],"award-info":[{"award-number":["CRG\/2023\/002508"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bbrc.2026.153593","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:42:09Z","timestamp":1773474129000},"page":"153593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Case study, clinical trials, critical analysis and mechanistic overview of conventional and resistant breast cancer treatment using functionalized albumin nanoparticles: a comprehensive review"],"prefix":"10.1016","volume":"813","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4575-9602","authenticated-orcid":false,"given":"Shuvadip","family":"Bhowmik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-6021","authenticated-orcid":false,"given":"Abhimanyu","family":"Dev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s11095-014-1549-2","article-title":"Generation dependent safety and efficacy of Folic Acid conjugated dendrimer based anticancer drug formulations: kesharwani, tekade and Jain","volume":"32","author":"Kesharwani","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbrc.2026.153593_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113427","article-title":"Revolutionizing breast cancer treatment: harnessing the potential of albumin nanoparticles as targeted drug delivery vehicles","volume":"220","author":"Verma","year":"2024","journal-title":"Eur. Polym. J."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1208\/s12249-025-03102-x","article-title":"Functionalized niosomes for Co-Delivery of curcumin and imatinib mesylate to treat breast cancer: in vitro and in vivo investigations","volume":"26","author":"Aparajay","year":"2025","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bbrc.2026.153593_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2022.112422","article-title":"Targeted delivery of albumin nanoparticles for breast cancer: a review","volume":"213","author":"Kunde","year":"2022","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2026.153593_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103070","article-title":"Breast cancer: an insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs","volume":"154","author":"Harwansh","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbrc.2026.153593_bib6","year":"2025","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bbrc.2026.153593_bib7","year":"2022","journal-title":"GLOBOCAN"},{"key":"10.1016\/j.bbrc.2026.153593_bib8","article-title":"Synthesis, characterization and in vitro assessment of colloidal gold nanoparticles of Gemcitabine with natural polysaccharides for treatment of breast cancer","volume":"56","author":"Devi","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153593_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105890","article-title":"Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer","volume":"164","author":"Dubey","year":"2021","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2026.153593_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112530","article-title":"Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer","volume":"146","author":"Sheikh","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib11","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/1061186X.2024.2333866","article-title":"Aptamer as a targeted approach towards treatment of breast cancer","volume":"32","author":"Bisht","year":"2024","journal-title":"J. Drug Target."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib12","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resistance"},{"key":"10.1016\/j.bbrc.2026.153593_bib13","article-title":"Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies","volume":"9","author":"Nounou","year":"2015","journal-title":"Breast Cancer Basic Clin. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib14","doi-asserted-by":"crossref","first-page":"339","DOI":"10.15171\/apb.2017.041","article-title":"The different mechanisms of cancer drug resistance: a brief review","volume":"7","author":"Mansoori","year":"2017","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib15","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib16","first-page":"930","article-title":"Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance","volume":"3","author":"Hassanin","year":"2020","journal-title":"Cancer Drug Resistance"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153593_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc903","article-title":"Ligand-targeted therapeutics in anticancer therapy","volume":"2","author":"Allen","year":"2002","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jconrel.2007.08.006","article-title":"Tumor pH-responsive flower-like micelles of poly (L-lactic acid)-b-poly (ethylene glycol)-b-poly (L-histidine)","volume":"123","author":"Lee","year":"2007","journal-title":"J. Contr. Release"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1021\/mp900021q","article-title":"In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer","volume":"6","author":"Kim","year":"2009","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153593_bib21","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153593_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/cancers10120483","article-title":"Sensitization of drug resistant cancer cells: a matter of combination therapy","volume":"10","author":"Leary","year":"2018","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib23","doi-asserted-by":"crossref","first-page":"212","DOI":"10.20892\/j.issn.2095-3941.2017.0054","article-title":"Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer","volume":"14","author":"Zhang","year":"2017","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib24","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00280-017-3427-1","article-title":"The potential of multi-compound nanoparticles to bypass drug resistance in cancer","volume":"80","author":"Da Silva","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153593_bib25","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1080\/10717544.2016.1178825","article-title":"Nanoparticle delivery of anticancer drugs overcomes multidrug resistance in breast cancer","volume":"23","author":"Yuan","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bbrc.2026.153593_bib26","article-title":"Nanotechnology-based drug delivery for breast cancer treatment: current applications and future directions","volume":"14","author":"Samad","year":"2025","journal-title":"European J.Med.Chem.Rep."},{"key":"10.1016\/j.bbrc.2026.153593_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40591-016-0048-8","article-title":"Albumin-based drug delivery: harnessing nature to cure disease","volume":"4","author":"Larsen","year":"2016","journal-title":"Mol. Cell.Therap."},{"issue":"34","key":"10.1016\/j.bbrc.2026.153593_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202503022","article-title":"Design and evaluation of Albumin\u2010Based Surface functionalized nanoparticles for targeting breast cancer","volume":"10","author":"Rathore","year":"2025","journal-title":"ChemistrySelect"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153593_bib30","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.3390\/cancers13123011","article-title":"Albumin-based nanoparticles for the delivery of doxorubicin in breast cancer","volume":"13","author":"Prajapati","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ddr.10157","article-title":"Biopolymer albumin for diagnosis and in drug delivery","volume":"58","author":"Patil","year":"2003","journal-title":"Drug Dev. Res."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153593_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/biom9060218","article-title":"Albumin nanovectors in cancer therapy and imaging","volume":"9","author":"Parodi","year":"2019","journal-title":"Biomolecules"},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0168-3659(99)00248-5","article-title":"Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review","volume":"65","author":"Maeda","year":"2000","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153593_bib34","first-page":"2920","article-title":"Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches","volume":"12","author":"Tufail","year":"2022","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2019.188310","article-title":"Mechanisms of acquired tumor drug resistance","volume":"1872","author":"Aleksakhina","year":"2019","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.153593_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.compbiolchem.2018.12.007","article-title":"Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer","volume":"78","author":"Lu","year":"2019","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.153593_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100210","article-title":"Understanding drug resistance in breast cancer: mechanisms and emerging therapeutic strategies","author":"Gautam","year":"2025","journal-title":"Med. Drug Dis."},{"issue":"23","key":"10.1016\/j.bbrc.2026.153593_bib38","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/1078-0432.CCR-07-1399","article-title":"The dynamics of estrogen receptor status in breast cancer: re-shaping the paradigm","volume":"13","author":"Lopez-Tarruella","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.bbrc.2026.153593_bib39","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1158\/0008-5472.CAN-08-1404","article-title":"Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts","volume":"68","author":"Creighton","year":"2008","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.bbrc.2026.153593_bib40","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jnci\/dji249","article-title":"Estrogen receptor\u2013positive, progesterone receptor\u2013negative breast cancer: association with growth factor receptor expression and tamoxifen resistance","volume":"97","author":"Arpino","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"30","key":"10.1016\/j.bbrc.2026.153593_bib41","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1200\/JCO.2005.09.004","article-title":"Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy","volume":"23","author":"Cui","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib42","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/cancers15041320","article-title":"Targeted therapy and mechanisms of drug resistance in breast cancer","volume":"15","author":"Kinnel","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153593_bib43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.msec.2017.08.004","article-title":"Albumin based versatile multifunctional nanocarriers for cancer therapy: fabrication, surface modification, multimodal therapeutics and imaging approaches","volume":"81","author":"Kudarha","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153593_bib44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","article-title":"Albumin nanostructures as advanced drug delivery systems","volume":"13","author":"Karimi","year":"2016","journal-title":"Expet Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/10717544.2019.1704945","article-title":"Albumin-based cancer therapeutics for intraperitoneal drug delivery: a review","volume":"27","author":"Van de Sande","year":"2020","journal-title":"Drug Deliv."},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib57","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(03)00134-0","article-title":"Optimization of the preparation process for human serum albumin (HSA) nanoparticles","volume":"257","author":"Langer","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0378-5173(99)00370-1","article-title":"Desolvation process and surface characterisation of protein nanoparticles","volume":"194","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijpharm.2009.04.033","article-title":"Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles","volume":"376","author":"Gong","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib60","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.biomaterials.2011.10.050","article-title":"Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types","volume":"33","author":"Bae","year":"2012","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/bip.20539","article-title":"Nanogels prepared by self\u2010assembly of oppositely charged globular proteins","volume":"83","author":"Yu","year":"2006","journal-title":"Biopolymers: Original Res. Biomol."},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib62","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2010.03.063","article-title":"Nanoparticles with dextran\/chitosan shell and BSA\/chitosan core\u2014doxorubicin loading and delivery","volume":"393","author":"Qi","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.bbrc.2026.153593_bib63","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1021\/ja043042m","article-title":"Polymer micelle with cross-linked ionic core","volume":"127","author":"Bronich","year":"2005","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153593_bib64","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.7150\/jca.30323","article-title":"Co-delivery of cyclopamine and doxorubicin mediated by bovine serum albumin nanoparticles reverses doxorubicin resistance in breast cancer by down-regulating P-glycoprotein expression","volume":"10","author":"Lu","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib65","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1021\/bc1002295","article-title":"Targeted albumin-based nanoparticles for delivery of amphipathic drugs","volume":"22","author":"Xu","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.bbrc.2026.153593_bib66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2014.11.008","article-title":"Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer","volume":"197","author":"Choi","year":"2015","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153593_bib67","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/17425247.2020.1813713","article-title":"Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs","volume":"17","author":"Hassanin","year":"2020","journal-title":"Expet Opin. Drug Deliv."},{"issue":"8","key":"10.1016\/j.bbrc.2026.153593_bib68","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1021\/acsami.6b14390","article-title":"Biomimetic human serum albumin nanoparticle for efficiently targeting therapy to metastatic breast cancers","volume":"9","author":"Liu","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/157489209789206869","article-title":"Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery","volume":"4","author":"Fu","year":"2009","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1359-6349(10)70002-1","article-title":"Nanoparticle albumin-bound (nab\u2122)-paclitaxel: improving efficacy and tolerability by targeted drug delivery in metastatic breast cancer","volume":"8","author":"Cortes","year":"2010","journal-title":"European J.Canc.Suppl."},{"issue":"13","key":"10.1016\/j.bbrc.2026.153593_bib71","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib72","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","article-title":"Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel","volume":"12","author":"Desai","year":"2006","journal-title":"Clin. Cancer Res.: Off.J Am Assoc. Canc. Res."},{"key":"10.1016\/j.bbrc.2026.153593_bib73","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.2147\/IJN.S93835","article-title":"An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line","author":"Yu","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbrc.2026.153593_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118818","article-title":"High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin","volume":"572","author":"Chow","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2026.153593_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.apsusc.2019.145011","article-title":"Biofabrication of cerium oxide nanoparticles using emulsification for an efficient delivery of Benzyl isothiocyanate","volume":"510","author":"Uppal","year":"2020","journal-title":"Appl. Surf. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12272-020-01204-7","article-title":"Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy","volume":"43","author":"Lamichhane","year":"2020","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.bbrc.2026.153593_bib47","article-title":"Recent advances in tumor targeting via EPR effect for cancer treatment","author":"Filipczak","year":"2021","journal-title":"J. Personalized Med."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153593_bib48","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.3390\/cancers14122868","article-title":"An updated review on EPR-based solid tumor targeting nanocarriers for cancer treatment","volume":"14","author":"Sharifi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bbrc.2026.153593_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib50","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.153593_bib51","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.colsurfb.2018.10.013","article-title":"Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo","volume":"173","author":"Min","year":"2019","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/pharmaceutics11020063","article-title":"Transferrin-conjugated polymeric nanoparticle for receptor-mediated delivery of doxorubicin in doxorubicin-resistant breast cancer cells","volume":"11","author":"Soe","year":"2019","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.nano.2017.10.010","article-title":"CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer","volume":"14","author":"Agrawal","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib54","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1080\/10717544.2019.1669734","article-title":"Novel multifunctional triple folic acid, biotin and CD44 targeting pH-sensitive nano-actiniaes for breast cancer combinational therapy","volume":"26","author":"Liu","year":"2019","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib55","first-page":"1396","article-title":"Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer","volume":"39","author":"Xiong","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.153593_bib56","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijbiomac.2019.02.129","article-title":"Aptamer functionalized curcumin-loaded human serum albumin (HSA) nanoparticles for targeted delivery to HER-2 positive breast cancer cells","volume":"130","author":"Saleh","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"28","key":"10.1016\/j.bbrc.2026.153593_bib76","doi-asserted-by":"crossref","first-page":"12678","DOI":"10.1039\/D1NJ01492G","article-title":"Bovine serum albumin interactive one dimensional hexanuclear manganese (iii) complex: synthesis, structure, binding and molecular docking studies","volume":"45","author":"Khatun","year":"2021","journal-title":"New J. Chem."},{"issue":"47","key":"10.1016\/j.bbrc.2026.153593_bib77","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1039\/C4TB01102C","article-title":"Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumor-targeting delivery system","volume":"2","author":"Qi","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"12","key":"10.1016\/j.bbrc.2026.153593_bib78","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/cbin.11455","article-title":"Cholesterol\u2010conjugated bovine serum albumin nanoparticles as a tamoxifen tumor\u2010targeted delivery system","volume":"44","author":"Gharbavi","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbrc.2026.153593_bib79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bioorg.2017.12.033","article-title":"Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug","volume":"76","author":"Nosrati","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bbrc.2026.153593_bib80","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.colsurfb.2018.07.016","article-title":"Beta-carotene-bound albumin nanoparticles modified with chlorin e6 for breast tumor ablation based on photodynamic therapy","volume":"171","author":"Phuong","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2026.153593_bib81","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2019.04.025","article-title":"A novel theranostic system of AS1411 aptamer-functionalized albumin nanoparticles loaded on iron oxide and gold nanoparticles for doxorubicin delivery","volume":"564","author":"Baneshi","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2026.153593_bib82","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijbiomac.2020.02.106","article-title":"Folate receptor alpha targeted delivery of artemether to breast cancer cells with folate-decorated human serum albumin nanoparticles","volume":"152","author":"Akbarian","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/cbdd.12624","article-title":"Biotin\/folate\u2010decorated human serum albumin nanoparticles of docetaxel: comparison of chemically conjugated nanostructures and physically loaded nanoparticles for targeting of breast cancer","volume":"87","author":"Nateghian","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"issue":"12","key":"10.1016\/j.bbrc.2026.153593_bib84","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/bc8002452","article-title":"Specific targeting of HER2 overexpressing breast cancer cells with doxorubicin-loaded trastuzumab-modified human serum albumin nanoparticles","volume":"19","author":"Anhorn","year":"2008","journal-title":"Bioconjug. Chem."},{"issue":"29","key":"10.1016\/j.bbrc.2026.153593_bib85","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/j.biomaterials.2008.07.001","article-title":"Effect of trastuzumab-modified antisense oligonucleotide-loaded human serum albumin nanoparticles prepared by heat denaturation","volume":"29","author":"Steinhauser","year":"2008","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib86","article-title":"Dual-targeted drug delivery system based on dopamine functionalized human serum albumin nanoparticles as a carrier for methyltestosterone drug","volume":"8","author":"Noori","year":"2021","journal-title":"Nanomed. J."},{"issue":"13","key":"10.1016\/j.bbrc.2026.153593_bib87","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1021\/acsami.5b00858","article-title":"Hybrid paclitaxel and gold nanorod-loaded human serum albumin nanoparticles for simultaneous chemotherapeutic and photothermal therapy on 4T1 breast cancer cells","volume":"7","author":"Peralta","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbrc.2026.153593_bib88","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.ijbiomac.2017.10.072","article-title":"Cross-linked ovalbumin catalyzed by polyphenol oxidase: preparation, structure and potential allergenicity","volume":"107","author":"Liu","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2026.153593_bib89","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.foodhyd.2018.03.048","article-title":"Characterization and interfacial rheological properties of nanoparticles prepared by heat treatment of ovalbumin-carboxymethylcellulose complexes","volume":"82","author":"Xiong","year":"2018","journal-title":"Food Hydrocoll."},{"issue":"24","key":"10.1016\/j.bbrc.2026.153593_bib90","doi-asserted-by":"crossref","first-page":"20315","DOI":"10.1021\/acsami.8b04312","article-title":"Injectable hydrogels coencapsulating granulocyte-macrophage colony-stimulating factor and ovalbumin nanoparticles to enhance antigen uptake efficiency","volume":"10","author":"Sun","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bbrc.2026.153593_bib91","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.foodhyd.2019.02.016","article-title":"Self-assembled nanoparticles from heat treated ovalbumin as nanocarriers for polyunsaturated fatty acids","volume":"93","author":"Visentini","year":"2019","journal-title":"Food Hydrocoll."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153593_bib92","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1039\/D0FO00755B","article-title":"Physicochemical and antibacterial properties of fabricated ovalbumin\u2013carvacrol gel nanoparticles","volume":"11","author":"Rao","year":"2020","journal-title":"Food Funct."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153593_bib93","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1039\/C8FO02416B","article-title":"Simulated gastrointestinal digestion of inclusion complexes based on ovalbumin nanoparticles and conjugated linoleic acid","volume":"10","author":"Visentini","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.bbrc.2026.153593_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120625","article-title":"Bovine serum albumin encapsulation of near infrared fluorescent nano-probe with low nonspecificity and cytotoxicity for imaging of HER2-positive breast cancer cells","volume":"210","author":"Wei","year":"2020","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib95","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jconrel.2004.01.029","article-title":"Tumour cell delivery of antisense oligonuclceotides by human serum albumin nanoparticles","volume":"96","author":"Wartlick","year":"2004","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.153593_bib96","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jconrel.2018.02.039","article-title":"Dual-stimuli-responsive albumin-polyplex nanoassembly for spatially controlled gene release in metastatic breast cancer","volume":"276","author":"Rajendrakumar","year":"2018","journal-title":"J. Contr. Release"},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib97","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijpharm.2015.02.037","article-title":"The potential use of lapatinib-loaded human serum albumin nanoparticles in the treatment of triple-negative breast cancer","volume":"484","author":"Wan","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib98","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijpharm.2012.04.033","article-title":"The in vivo antitumor activity of LHRH targeted methotrexate\u2013human serum albumin nanoparticles in 4T1 tumor-bearing Balb\/c mice","volume":"431","author":"Taheri","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib99","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijpharm.2013.02.043","article-title":"Optimization of an anti-HER2 monoclonal antibody targeted delivery system using PEGylated human serum albumin nanoparticles","volume":"447","author":"Kouchakzadeh","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153593_bib100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijpharm.2016.10.066","article-title":"Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer","volume":"515","author":"Esfandyari-Manesh","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2026.153593_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2020.125501","article-title":"Bovine serum albumin nanoparticles for the efficient delivery of berberine: preparation, characterization and in vitro biological studies","volume":"608","author":"Solanki","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bbrc.2026.153593_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123570","article-title":"Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: a dual-death therapy for triple negative breast cancer","volume":"648","author":"Ghadi","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbrc.2026.153593_bib103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.colsurfb.2018.02.024","article-title":"Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells","volume":"165","author":"Galisteo-Gonz\u00e1lez","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2026.153593_bib104","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.colsurfb.2015.10.018","article-title":"Incorporation of lapatinib into human serum albumin nanoparticles with enhanced anti-tumor effects in HER2-positive breast cancer","volume":"136","author":"Wan","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ejps.2012.06.016","article-title":"Trastuzumab decorated methotrexate\u2013human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells","volume":"47","author":"Taheri","year":"2012","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2026.153593_bib106","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.msec.2013.09.004","article-title":"In situ synthesized BSA capped gold nanoparticles: effective carrier of anticancer drug methotrexate to MCF-7 breast cancer cells","volume":"34","author":"Murawala","year":"2014","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.bbrc.2026.153593_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111777","article-title":"Genistein loaded in self-assembled bovine serum albumin nanovehicles and their effects on mouse mammary adenocarcinoma cells","volume":"204","author":"Ferrado","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2026.153593_bib108","article-title":"Cell uptake and anti-tumor effect of liposomes containing encapsulated paclitaxel-bound albumin against breast cancer cells in 2D and 3D cultured models","volume":"55","author":"Okamoto","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153593_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.114575","article-title":"Bovine serum albumin-gold nanoclusters protein corona stabilized polystyrene nanoparticles as dual-color fluorescent nanoprobes for breast cancer detection","volume":"215","author":"Wu","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.bbrc.2026.153593_bib110","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jddst.2019.05.033","article-title":"Human serum albumin: a nanomedicine platform targeting breast cancer cells","volume":"52","author":"Lee","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153593_bib111","article-title":"Targeted albumin nanoparticles for the enhancement of gemcitabine toxicity on cancerous cells","volume":"56","author":"Mohammadian","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153593_bib112","article-title":"Biomimetic cancer cell-coated albumin nanoparticles for enhanced colloidal stability and homotypic targeting of breast cancer cells","volume":"75","author":"Cao","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153593_bib113","article-title":"Preparation and evaluation of folate-modified albumin baicalin-loaded nanoparticles for the targeted treatment of breast cancer","volume":"65","author":"Meng","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbrc.2026.153593_bib114","article-title":"Multifunctional bovine serum albumin-based nanocarriers with endosomal escaping and NIR light-controlled release to overcome multidrug resistance of breast cancer cells","volume":"77","author":"Gao","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib115","first-page":"508","article-title":"Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer","volume":"16","author":"Tan","year":"2021","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.bbrc.2026.153593_bib116","first-page":"525","article-title":"Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis","author":"Sebak","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbrc.2026.153593_bib117","doi-asserted-by":"crossref","first-page":"6971","DOI":"10.2147\/IJN.S210882","article-title":"Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo","author":"Dong","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153593_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188639","article-title":"Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231","volume":"12","author":"Azizi","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib119","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/2230-973X.82432","article-title":"Preparation and characterization of albumin nanoparticles encapsulating curcumin intended for the treatment of breast cancer","volume":"1","author":"Jithan","year":"2011","journal-title":"Int. J. Pharm. Investig."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/10717544.2021.1921078","article-title":"Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models","volume":"28","author":"Chen","year":"2021","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib121","article-title":"Cationic albumin nanoparticles for enhanced drug delivery to treat breast cancer: preparation and in vitro assessment","volume":"2012","author":"Abbasi","year":"2012","journal-title":"J. Drug Delivery"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153593_bib122","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/02652048.2019.1671908","article-title":"Smart albumin-loaded Rose Bengal and doxorubicin nanoparticles for breast cancer therapy","volume":"36","author":"Sun","year":"2019","journal-title":"J. Microencapsul."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153593_bib123","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.7150\/jca.19364","article-title":"Downregulation of ABC transporters in non-neoplastic tissues confers better prognosis for pancreatic and colorectal cancer patients","volume":"8","author":"Dvorak","year":"2017","journal-title":"J. Cancer"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib124","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7150\/thno.22679","article-title":"Stimuli-responsive nanomedicines for overcoming cancer multidrug resistance","volume":"8","author":"Zhou","year":"2018","journal-title":"Theranostics"},{"issue":"6799","key":"10.1016\/j.bbrc.2026.153593_bib125","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/35023008","article-title":"Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine","volume":"406","author":"Taipale","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib126","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1007\/s13277-015-3997-7","article-title":"Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7\/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells","volume":"37","author":"Liu","year":"2016","journal-title":"Tumor Biol."},{"issue":"21","key":"10.1016\/j.bbrc.2026.153593_bib127","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2217\/nnm-2018-0206","article-title":"Chemosensitizer and docetaxel-loaded albumin nanoparticle: overcoming drug resistance and improving therapeutic efficacy","volume":"13","author":"Desale","year":"2018","journal-title":"Nanomedicine"},{"issue":"11","key":"10.1016\/j.bbrc.2026.153593_bib140","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.3390\/molecules23112760","article-title":"VE-albumin core-shell nanoparticles for paclitaxel delivery to treat MDR breast cancer","volume":"23","author":"Tang","year":"2018","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s41048-018-0079-6","article-title":"Co-encapsulation of curcumin and doxorubicin in albumin nanoparticles blocks the adaptive treatment tolerance of cancer cells","volume":"5","author":"Motevalli","year":"2019","journal-title":"Biophys. Rep."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.canlet.2013.12.001","article-title":"Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis","volume":"346","author":"Ji","year":"2014","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153593_bib129","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1158\/0008-5472.CAN-11-3831","article-title":"Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma","volume":"72","author":"Hu","year":"2012","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153593_bib130","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.bbrc.2026.153593_bib131","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1158\/1078-0432.CCR-11-2711","article-title":"Tumor hypoxia predicts biochemical failure following radiotherapy for clinically localized prostate cancer","volume":"18","author":"Milosevic","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"20","key":"10.1016\/j.bbrc.2026.153593_bib132","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-12-0858","article-title":"Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy","volume":"18","author":"Meijer","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib133","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12274-014-0558-0","article-title":"Mesoporous silica nanorods intrinsically doped with photosensitizers as a multifunctional drug carrier for combination therapy of cancer","volume":"8","author":"Yang","year":"2015","journal-title":"Nano Res."},{"issue":"33","key":"10.1016\/j.bbrc.2026.153593_bib134","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1002\/adma.201602111","article-title":"Catalase-Loaded TaOx nanoshells as bio-nanoreactors combining High-Z element and enzyme delivery for enhancing radiotherapy","volume":"28","author":"Song","year":"2016","journal-title":"Adv. mater.(Deerfield Beach, Fla.)"},{"issue":"6387","key":"10.1016\/j.bbrc.2026.153593_bib135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/358591a0","article-title":"The catalase\u2014peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis","volume":"358","author":"Zhang","year":"1992","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib136","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1021\/la991161n","article-title":"Enzyme encapsulation in layer-by-layer engineered polymer multilayer capsules","volume":"16","author":"Caruso","year":"2000","journal-title":"Langmuir"},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib137","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nnano.2012.264","article-title":"Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication","volume":"8","author":"Liu","year":"2013","journal-title":"Nat. Nanotechnol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib138","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1021\/ja511420n","article-title":"H2O2-activatable and O2-evolving nanoparticles for highly efficient and selective photodynamic therapy against hypoxic tumor cells","volume":"137","author":"Chen","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2026.153593_bib139","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jconrel.2016.11.006","article-title":"Drug-induced co-assembly of albumin\/catalase as smart nano-theranostics for deep intra-tumoral penetration, hypoxia relieve, and synergistic combination therapy","volume":"263","author":"Chen","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bbrc.2026.153593_bib142","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.actbio.2018.03.057","article-title":"Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management","volume":"73","author":"Kushwah","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bbrc.2026.153593_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.213039","article-title":"pH-responsive albumin-coated biopolymeric nanoparticles with lapatinab for targeted breast cancer therapy","volume":"139","author":"Iqbal","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bbrc.2026.153593_bib144","doi-asserted-by":"crossref","first-page":"7051","DOI":"10.2147\/IJN.S332830","article-title":"Cetuximab-modified human serum albumin nanoparticles co-loaded with doxorubicin and MDR1 siRNA for the treatment of drug-resistant breast tumors","author":"Yang","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib145","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1038\/s41598-017-05461-3","article-title":"Anti-cancerous effect of albumin coated silver nanoparticles on MDA-MB 231 human breast cancer cell line","volume":"7","author":"Azizi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.153593_bib156","year":"2025","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153593_bib146","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/pharmaceutics17101290","article-title":"Albumin nanoparticles in cancer therapeutics: clinical status, challenges, and future directions","volume":"17","author":"Kadri","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2026.153593_bib147","article-title":"Nanoparticle albumin-bound paclitaxel (nab-Paclitaxel): bridging pharmacology and translational medicine in breast cancer","author":"Alkhathami","year":"2025","journal-title":"Current Res. Transl.Med."},{"key":"10.1016\/j.bbrc.2026.153593_bib148","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.760655","article-title":"Efficacy and safety of albumin-bound paclitaxel compared to docetaxel as neoadjuvant chemotherapy for HER2-negative breast cancer","volume":"11","author":"Lv","year":"2022","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153593_bib149","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/CAD.0b013e32830f9046","article-title":"Improved effectiveness of nanoparticle albumin-bound (nab) paclitaxel versus polysorbate-based docetaxel in multiple xenografts as a function of HER2 and SPARC status","volume":"19","author":"Desai","year":"2008","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.bbrc.2026.153593_bib150","series-title":"Metastatic Breast Cancer","author":"Gradishar","year":"2013"},{"issue":"8","key":"10.1016\/j.bbrc.2026.153593_bib151","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.addr.2007.08.044","article-title":"Protein nanoparticles as drug carriers in clinical medicine","volume":"60","author":"Hawkins","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2026.153593_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122711","article-title":"Preclinical evaluation of albumin-bound docetaxel nanoparticles as potential anti-cancer products","volume":"635","author":"Su","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153593_bib153","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/13543784.17.3.335","article-title":"New taxanes in development","volume":"17","author":"Ferlini","year":"2008","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"4","key":"10.1016\/j.bbrc.2026.153593_bib154","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0305-7372(93)90010-O","article-title":"The taxoids: Paclitaxel (Taxol\u00ae) and docetaxel (Taxotere\u00ae)","volume":"19","author":"Pazdur","year":"1993","journal-title":"Cancer Treat Rev."},{"issue":"19","key":"10.1016\/j.bbrc.2026.153593_bib157","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1007\/s00216-017-0403-x","article-title":"An efficient direct competitive nano-ELISA for residual BSA determination in vaccines","volume":"409","author":"Wang","year":"2017","journal-title":"Anal. Bioanal. Chem."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib158","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jbm.10145","article-title":"Cytotoxicity of glutaraldehyde crosslinked collagen\/poly (vinyl alcohol) films is by the mechanism of apoptosis","volume":"61","author":"Gough","year":"2002","journal-title":"J. Biomed. Mater. Res.: Off.J. Soc. Biomater., Japanese Soc. Biomater.Australian Soc.Biomater. Korean Soc. Biomater."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153593_bib159","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jps.2600620211","article-title":"Toxicological studies of 2-mercaptoethanol","volume":"62","author":"White","year":"1973","journal-title":"J. Pharmaceut. Sci."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153593_bib160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1021\/bm201401s","article-title":"Molecular switch for the assembly of lipophilic drug incorporated plasma protein nanoparticles and in vivo image","volume":"13","author":"Gong","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bbrc.2026.153593_bib161","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.phrs.2016.12.021","article-title":"Effect of lysosomotropic molecules on cellular homeostasis","volume":"117","author":"Kuzu","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2026.153593_bib162","article-title":"Albumin-based nanocarriers: singularities, synthesis methods, clinical relevance and targeting strategies in cancer","volume":"B","author":"P\u00e9rez-Herrero","year":"2025","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.bbrc.2026.153593_bib163","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fphar.2018.00790","article-title":"Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization","volume":"9","author":"Hua","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:55:38Z","timestamp":1776113738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26003578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":162,"alternative-id":["S0006291X26003578"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153593","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Case study, clinical trials, critical analysis and mechanistic overview of conventional and resistant breast cancer treatment using functionalized albumin nanoparticles: a comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153593"}}